Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FoviOptics was a medical technology company focused on developing non-invasive glucose monitoring systems using advanced optical sensors. The company's core technology leveraged Raman spectroscopy to measure blood glucose levels through the skin, aiming to eliminate the need for invasive finger-stick tests. Founded in 2007, the startup sought to integrate this technology into portable and wearable formats for better diabetes management. In 2013, FoviOptics was acquired by Apple, and its intellectual property and engineering talent were integrated into Apple's health technology division. This acquisition played a significant role in the development of health-related features for the Apple Watch and subsequent wearable products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FoviOptics.